Search results for "World Health"

showing 10 items of 184 documents

Manganese: A New Emerging Contaminant in the Environment

2012

The environment is composed of the atmosphere, earth and water. According to the World Health Organization, more than 100,000 chemicals are released into the global ambient every year as a consequence of their production, use and disposal. The fate of a chemical substance depends on its chemical application and physical-chemical properties, in combination with the characteristics of the environment where it is released. Chemical substances or contaminants discharged into the environment may be “natural” or “manmade”. One of the most misunderstood concepts regarding contamination is the missinterpretation of term “natural”. A “natural” contaminant is one substance that can occur without huma…

0303 health sciencesfungichemistry.chemical_elementManganese010501 environmental sciencesContamination01 natural sciencesNatural (archaeology)World health3. Good health03 medical and health sciencesSea urchin embryos manganese developmentchemistry13. Climate actionEnvironmental chemistryEnvironmental scienceEarth (chemistry)Settore BIO/06 - Anatomia Comparata E Citologia030304 developmental biology0105 earth and related environmental sciences
researchProduct

White Book on Physical and Rehabilitation Medicine in Europe. Introductions, Executive Summary, and Methodology

2018

The White Book (WB) of Physical and Rehabilitation Medicine (PRM) in Europe is produced by the 4 European PRM Bodies (European Academy of Rehabilitation Medicine - EARM, European Society of PRM - ESPRM, European Union of Medical Specialists - PRM Section, European College of PRM-ECPRM served by the European Union of Medical Specialists-PRM Board) and constitutes the reference book for PRM physicians in Europe. It has now reached its third edition; the first was published in 1989 and the second in 2006/2007. The WB has multiple purposes, including providing a unifying framework for European countries, to inform decision-makers on European and national level, to offer educational material for…

030506 rehabilitationmedicine.medical_specialtymedicine.medical_treatmentSpecialtyPhysical Therapy Sports Therapy and RehabilitationWorld healthConvention03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationHumansMedicinemedia_common.cataloged_instanceDisabled PersonsBooks* Disabled Persons/rehabilitation* Europe Humans Physical and Rehabilitation Medicine*FunctioningEuropean unionCompetence (human resources)media_commonDisabilityExecutive summaryRehabilitationbusiness.industryBooksRehabilitationPhysical and Rehabilitation MedicineEuropeAction plan0305 other medical sciencebusiness030217 neurology & neurosurgeryEuropean Journal of Physical and Rehabilitation Medicine
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct

Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.

2002

<i>Objective:</i> This study was designed to determine the maximum tolerable dose (MTD) of gemcitabine plus docetaxel, both given on a weekly schedule, in patients with pretreated metastatic breast cancer (MBC). <i>Methods:</i> Heavily pretreated patients with MBC, aged 18–75 years with World Health Organization performance status of 0–2 were enrolled. Three escalating weekly doses of docetaxel (30, 35 and 40 mg/m<sup>2</sup>) followed by a weekly fixed dose of gemcitabine, 800 mg/m<sup>2</sup>, were administered on days 1, 8 and 15 of a 28-day cycle. Dose-limiting toxicity (DLT) included grade >3 hematologic toxicity and grade >2 stomat…

AdultCancer Researchmedicine.medical_specialtyLung NeoplasmsPaclitaxelmedicine.drug_classmedicine.medical_treatmentBone NeoplasmsBreast NeoplasmsDocetaxelWorld Health OrganizationAntimetaboliteGastroenterologyDeoxycytidineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisAgedChemotherapyPerformance statusDose-Response Relationship Drugbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerGemcitabineGemcitabineSurgeryRegimenTreatment OutcomeOncologyDocetaxelLymphatic MetastasisToxicityFemaleTaxoidsbusinessmedicine.drugOncology
researchProduct

The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted…

1994

This report from the WHO project on Psychological Problems in General Health Care examines the relevance in primary care of the concept of recurrent brief depression (RBD) proposed by Jules Angst. RBD refers to brief, severe depressive episodes that recur frequently, i.e. nearly once a month over, a 1-year period, according to Angst. Using a structured interview (CIDI), RBD was assessed in patients not meeting the criteria for depressive episodes lasting at least 2 weeks, as defined in the ICD-10 (DE). A substantial proportion of primary care seekers were identified as presenting RBD without other depressive disorders, 3.7% with a formal RBD diagnosis and 2.7% with frequent but not monthly …

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricsPoison controlSuicide AttemptedComorbidityWorld Health OrganizationSuicide preventionOccupational safety and healthRecurrent brief depressionRecurrenceInjury preventionmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderPrimary Health Carebusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaseCIDIComorbidityPsychiatry and Mental healthCross-Sectional StudiesFemalebusinessEuropean archives of psychiatry and clinical neuroscience
researchProduct

Subjective quality of life among youth with severe physical disabilities during the transition to adulthood in Finland

2018

Purpose: This study examined the subjective quality of life among youth with severe physical disabilities during the transition to adulthood.Method: A purposive sample of 74 youths (mean age 20.19)...

AdultGerontology030506 rehabilitationAdolescentRehabilitationMean ageSample (statistics)World Health OrganizationDisabled ChildrenYoung Adult03 medical and health sciencesSex Factors0302 clinical medicineQuality of LifeHumansDisabled Persons0305 other medical sciencePsychologySubjective qualityFinland030217 neurology & neurosurgeryDisability and Rehabilitation
researchProduct

The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia

2019

Background & Aims In 2015, the World Health Organization (WHO) issued guidelines for the management of chronic hepatitis B (CHB) in low- and middle-income countries, but little is known about the applicability of the WHO treatment criteria in sub-Saharan Africa. The aim of this study was to evaluate the diagnostic performance of the WHO guidelines in a large CHB cohort in Ethiopia. Methods Treatment-naive adults who attended a public CHB clinic in Addis Ababa were included in this analysis. All patients underwent a standardized evaluation at recruitment, including blood tests and transient elastography (Fibroscan®). A Fibroscan result >7.9 kPa was used to define significant fibrosis and >9.…

AdultMale0301 basic medicinemedicine.medical_specialtyCirrhosisWorld Health Organization03 medical and health sciencesHepatitis B Chronic0302 clinical medicineChronic hepatitisInternal medicinemedicineHumansHepatologybusiness.industryGold standardAntiviral therapyAlanine Transaminasemedicine.disease030104 developmental biologyWho guidelinesPractice Guidelines as TopicCohortElasticity Imaging TechniquesFemale030211 gastroenterology & hepatologyEthiopiabusinessTransient elastographyViral hepatitisJournal of Hepatology
researchProduct

Risk assessment of benzene in food samples of Iran's market

2018

Abstract The concentration of benzene in ninety-eight collected food and drink samples (carbonated beverage, fruit juice, pickle, lime juice, mayonnaise and salad dressing, 16 samples from each) from Iran local markets were investigated using gas chromatography equipped with flame ionization detector (GC-FID). Moreover, the correlation of benzene concentration with sodium benzoate and ascorbic acid concentrations was assessed. Benzene concentration in carbonated beverages, fruit juices, pickle, lime juices, mayonnaise and salad dressing were 3.57 ± 1.70, 5.17 ± 3.63, 4.37 ± 2.24, 4.99 ± 0.54, 1.38 ± 0.87 and 1.47 ± 0.83 μg/L, respectively, being in all cases below the acceptable limit (10 μ…

AdultMaleAdolescentCarbonated BeveragesFood ContaminationAscorbic AcidIran010501 environmental sciencesengineering.materialToxicologyRisk Assessment01 natural sciencesGas Chromatography-Mass SpectrometryWorld healthlaw.inventionYoung Adultchemistry.chemical_compound0404 agricultural biotechnologylawHumansFlame ionization detectorFood scienceBenzene0105 earth and related environmental sciencesLimeLime JuiceBenzene04 agricultural and veterinary sciencesGeneral MedicineMiddle AgedAscorbic acid040401 food sciencechemistryengineeringSodium benzoateFemaleGas chromatographyFood ScienceFood and Chemical Toxicology
researchProduct

The association between different domains of quality of life and symptoms in primary care patients with emotional disorders

2018

AbstractDespite the importance of quality of life (QoL) in primary care patients with emotional disorders, the specific influence of the symptoms of these disorders and the sociodemographic characteristics of patients on the various QoL domains has received scant attention. The aim of the present study of primary care patients with emotional disorders was to analyse the associations between four different QoL domains and the most prevalent clinical symptoms (i.e., depression, anxiety and somatization), while controlling for sociodemographic variables. A total of 1241 participants from 28 primary care centres in Spain were assessed with the following instruments: the Patient Health Questionn…

AdultMaleAdolescentlcsh:MedicineAnxietyWorld Health OrganizationArticleYoung Adult03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesHumansMedicine030212 general & internal medicineYoung adultlcsh:ScienceSomatoform DisordersDepression (differential diagnoses)AgedMultidisciplinaryPrimary Health CareDepressionbusiness.industrylcsh:REmocionsMiddle Agedmedicine.diseaseExplained variationhumanities030227 psychiatryPatient Health QuestionnairePsicologiaSpainQuality of LifeRegression AnalysisMarital statusAnxietylcsh:QFemalemedicine.symptombusinessSomatizationClinical psychologyScientific Reports
researchProduct

Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.

2006

We reviewed a large series of patients with essential thrombocythemia diagnosed on the basis of the Polycythemia Vera Study Group criteria, and reclassified them by evaluating their major morphologic features and clinical course using the World Health Organization classification. The morphologic review of the bone marrow biopsies of 116 patients (44 males and 72 females; aged 19 - 83 years, median 55 years; median follow-up 121 months) led to 22 cases (19%) being classified as essential thrombocythemia (ET), 24 (21%) as chronic idiopathic myelofibrosis (CIMF)-0, 44 (37%) as CIMF-1, 13 (12%) as CIMF-2, 9 (8%) as latent phase polycythemia vera, and four (3%) as chronic myeloproliferative diso…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyIdiopathic myelofibrosisSingle CenterWorld healthDiagnosis DifferentialPolycythemia veraBone Marrowhemic and lymphatic diseasesmedicineHumansPolycythemia VeraAgedAged 80 and overEssential thrombocythemiabusiness.industryHistologyBone Marrow ExaminationHematologyMiddle Agedmedicine.diseaseHaematopoiesismedicine.anatomical_structureOncologyPrimary MyelofibrosisChronic DiseaseFemaleBone marrowbusinessGranulocytesThrombocythemia EssentialLeukemialymphoma
researchProduct